News & Analysis on Clinical Trial Services & Contract Research And Development
Chinese service provider WuXi PharmaTech has sold a 5.55% stake in its wholly owned CMO (contract manufacturing organization) subsidiary SynTheAll Pharmaceutical (STA) to members of STA’s and WuXi’s management for $28m.
AMRI has confirmed it will close its Holywell, UK facility and let go 62 employees from the site following a consultation with employee representatives.
Connecticut-based CMO Aptuit opened a 1600L/1000L reactor stream at its API facility in Oxford, UK, and increased throughput at its 400L reactors at its site in Verona, Italy.